ScoreWhy is BrightGene Bio-Medical Technology Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 11.00% and Operating profit at -25.90% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.15% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 11.00% and Operating profit at -25.90% over the last 5 years
3
The company has declared negative results for the last 6 consecutive quarters
- NET PROFIT(HY) At CNY 37.56 MM has Grown at -65.94%
- OPERATING CASH FLOW(Y) Lowest at CNY 210.71 MM
- NET SALES(9M) At CNY 874.25 MM has Grown at -10.36%
4
With ROE of 2.57%, it has a very expensive valuation with a 9.92 Price to Book Value
- Over the past year, while the stock has generated a return of 19.88%, its profits have fallen by -60.5%
- At the current price, the company has a high dividend yield of 0.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BrightGene Bio-Medical Technology Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
BrightGene Bio-Medical Technology Co., Ltd.
-69.45%
0.36
58.00%
China Shanghai Composite
8.25%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.01%
EBIT Growth (5y)
-23.73%
EBIT to Interest (avg)
5.95
Debt to EBITDA (avg)
5.17
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
0.25
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
12.40%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.27%
ROE (avg)
9.15%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
411
Industry P/E
Price to Book Value
5.92
EV to EBIT
321.61
EV to EBITDA
93.70
EV to Capital Employed
3.95
EV to Sales
12.82
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
1.23%
ROE (Latest)
1.44%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(HY)
At CNY 674.33 MM has Grown at 21.57%
RAW MATERIAL COST(Y)
Fallen by -48.29% (YoY
CASH AND EQV(HY)
Highest at CNY 2,356.42 MM
-31What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 101.69 MM
PRE-TAX PROFIT(Q)
At CNY -5.37 MM has Fallen at -268.59%
ROCE(HY)
Lowest at 2.02%
INTEREST(Q)
At CNY 18.58 MM has Grown at 27.39%
INTEREST COVERAGE RATIO(Q)
Lowest at 46.86
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.41 times
OPERATING PROFIT(Q)
Lowest at CNY 8.71 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 2.68 %
NET PROFIT(Q)
At CNY 6.7 MM has Fallen at -34.15%
Here's what is working for BrightGene Bio-Medical Technology Co., Ltd.
Net Sales
At CNY 674.33 MM has Grown at 21.57%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 2,356.42 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -48.29% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for BrightGene Bio-Medical Technology Co., Ltd.
Pre-Tax Profit
At CNY -5.37 MM has Fallen at -268.59%
over average net sales of the previous four periods of CNY 3.19 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 101.69 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest
At CNY 18.58 MM has Grown at 27.39%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 46.86
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 8.71 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 2.68 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
At CNY 6.7 MM has Fallen at -34.15%
over average net sales of the previous four periods of CNY 10.18 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Inventory Turnover Ratio
Lowest at 1.41 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
